Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A: data from the PedNet Hemophilia Cohort of 1,202 children

• Nadine G. Andersson,
• Veerle Labarque,
• Mutlu Kartal-Kaess,
• Fernando Pinto,
• Torben Stamm Mikkelsen,
• Rolf Ljung,
• PedNet Study Group

Affiliations

Nadine G. Andersson

Center for Thrombosis and Hemostasis, Skåne University Hospital, Malmö, Sweden; Department of Pediatrics, Skåne University Hospital, Lund, Sweden; Department of Clinical Sciences and Pediatrics, Lund University, Lund

Veerle Labarque

Department of Pediatrics, Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium

Mutlu Kartal-Kaess

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Inselspital, University Hospital, University of Bern, Bern

Fernando Pinto

Royal Hospital for Children, Glasgow, UK

Torben Stamm Mikkelsen

Department of Pediatric Oncology and Hematology, University Hospital, Aarhus, Denmark

Rolf Ljung

Department of Pediatrics, Skåne University Hospital, Lund

PedNet Study Group

PedNet group, Table S1, Supplement